TCM
ZYME icon

Tekla Capital Management’s Zymeworks ZYME Stock Holding History

Tekla Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-55,938
Closed -$2.64M – 216
2020
Q4 		$2.64M Hold
55,938
– – 0.09% 147
2020
Q3 		$2.61M Hold
55,938
– – 0.1% 139
2020
Q2 		$2.02M Buy
55,938
+40,746
+268% +$1.5M 0.08% 159
2020
Q1 		$539K Hold
15,192
– – 0.02% 194
2019
Q4 		$691K Hold
15,192
– – 0.03% 186
2019
Q3 		$377K Buy
+15,192
New +$381K 0.02% 177

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tekla Capital Management's ZYME Position: Q1 2021 in Review

Tekla Capital Management sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 55,938 shares — an estimated $2.64M sold.

Tekla Capital Management first reported a position in ZYME in Q3 2019 and held it in 6 quarters. The position peaked at $2.64M in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Tekla Capital Management reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Tekla Capital Management sold 55,938 Zymeworks shares in Q1 2021, an estimated $2.64M.
  • Tekla Capital Management first reported a position in Zymeworks in Q3 2019 and held it in 6 quarters.
  • Tekla Capital Management's Zymeworks position peaked at $2.64M in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Tekla Capital Management's 13F filing for Q1 2021, filed 14 May 2021.